Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on November 19, 2013. The report announces the issuance of a press release detailing financial results for the fiscal quarter ended September 30, 2013.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves solely as a notification that the results for the quarter ended September 30, 2013, have been announced via a press release.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The report contains forward-looking statements regarding intentions, beliefs, expectations, and strategies. These are based on current assumptions and are not guarantees of future performance.
- Risks and Uncertainties: Actual outcomes may differ materially due to risks discussed in the Company's Annual Report on Form 10-K and other SEC filings.
- Update Obligation: The Company does not undertake an obligation to update forward-looking statements to reflect events occurring after the date of this report, except as required by law.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, cash position) in the press release attached as Exhibit 99.1.
- Confirm the registrant name is Oculus Innovative Sciences, Inc. and not Sonoma Pharmaceuticals, Inc.
- Review the Company's most recent Form 10-K for detailed risk factors referenced in this filing.
- Check for any subsequent updates to the forward-looking statements made on November 19, 2013.